QIAGEN NV
QGENF
QGENF was delisted on the 14th of February, 2005.
187 hedge funds and large institutions have $3.03B invested in QIAGEN NV in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 64 increasing their positions, 76 reducing their positions, and 33 closing their positions.
130% more call options, than puts
Call options by funds: $2.23M | Put options by funds: $972K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
5% more capital invested
Capital invested by funds: $2.89B → $3.03B (+$143M)
7% less funds holding
Funds holding: 201 → 187 (-14)
16% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 76
33% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$85.1M |
| 2 |
HM
HealthCor Management
New York
|
+$54.5M |
| 3 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
+$37.7M |
| 4 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$32.1M |
| 5 |
Millennium Management
New York
|
+$28.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$25.5M |
| 2 |
Two Sigma Investments
New York
|
-$11.3M |
| 3 |
D.E. Shaw & Co
New York
|
-$11.1M |
| 4 |
BJCM
Blue Jay Capital Management
Los Angeles,
California
|
-$10.6M |
| 5 |
Primecap Management
Pasadena,
California
|
-$7.96M |
QGENF Hedge Fund Activity: Q2 2016 in Review
187 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q2 2016, worth a combined $3.03B — up 4.9% from $2.89B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of QGENF and 22 opened new positions — a net loss of 11 holders — while 76 trimmed existing stakes and 64 added.
The largest buyer was Norges Bank, opening a new position worth an estimated $85.1M. The largest seller was Fiera Capital (Canada), exiting entirely with an estimated $25.5M sold.
- 187 institutional investors held QIAGEN NV (QGENF) as of Q2 2016, down from 201 in Q1 2016.
- Funds reported $3.03B of QIAGEN NV stock for Q2 2016, up 4.9% quarter-over-quarter.
- 22 funds opened new QIAGEN NV positions in Q2 2016 and 33 closed out, a net change of -11 holders.
- The largest QIAGEN NV buyer in Q2 2016 was Norges Bank, an estimated $85.1M added.
- The largest QIAGEN NV seller in Q2 2016 was Fiera Capital (Canada), an estimated $25.5M sold.
Based on aggregated 13F filings for Q2 2016.